Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Active Biotech AB ( (SE:ACTI) ) has provided an announcement.
Active Biotech AB has announced its upcoming Annual General Meeting (AGM) scheduled for May 28, 2025. Key agenda items include the re-election of board members and auditors, with no dividend to be paid as the company’s accumulated loss will be carried forward. The meeting will also address board remuneration and share issue authorization, impacting the company’s governance and financial strategy moving forward.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer. The company is engaged in research and development to bring innovative therapies to market, aiming to improve patient outcomes in these areas.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
See more data about ACTI stock on TipRanks’ Stock Analysis page.